Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock

Anne Freund; Steffen Desch; Janine Pöss; Dmitry Sulimov; Marcus Sandri; Nicolas Majunke; Holger Thiele

doi:10.3390/jcm11051256

Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock

J Clin Med. 2022 Feb 25;11(5):1256. doi: 10.3390/jcm11051256.

Authors

Anne Freund^{1

2

3}, Steffen Desch^{1

2

3}, Janine Pöss^{1

2}, Dmitry Sulimov^{1

2}, Marcus Sandri^{1

2}, Nicolas Majunke^{1

2}, Holger Thiele^{1

2}

Affiliations

¹ Department of Internal Medicine/Cardiology, Heart Center Leipzig, University of Leipzig, Strümpellstr. 39, 04289 Leipzig, Germany.
² Leipzig Heart Institute, 04289 Leipzig, Germany.
³ German Center for Cardiovascular Research (DZHK), 10785 Berlin, Germany.

Abstract

Mortality in infarct-related cardiogenic shock (CS) remains high, reaching 40-50%. In refractory CS, active mechanical circulatory support devices including veno-arterial extracorporeal membrane oxygenation (VA-ECMO) are rapidly evolving. However, supporting evidence of VA-ECMO therapy in infarct-related CS is low. The current review aims to give an overview on the basics of VA-ECMO therapy, current evidence, ongoing trials, patient selection and potential complications.

Keywords: acute myocardial infarction; cardiogenic shock; extracorporeal life support; extracorporeal membrane oxygenation.

Publication types

Review